N95 Masks: New Guidance for Addressing Shortages

An ECRI lab tour

View a recording of our April 15, 2020, live-streamed lab webcast. This video features updated recommendations from ECRI experts on new CDC recommendations, expanded decontamination options—Sterrad and Battelle, and importing of equivalent N95 masks. This video addresses critically important issues impacting hospitals now as they care for patients with coronavirus. The presentation concludes with an informative Q&A session based on questions from hospitals around the globe.

Speakers

  • Dr. Andrew Furman, Executive Director, Clinical Excellence, ECRI
  • Amanda Sivek, PhD, Principal Project Officer I, Device Evaluation, ECRI
  • Chris Lavanchy, Engineering Director, Device Evaluation, ECRI
  • Tim Browne, Director, Supply Chain Services, ECRI
  • Jason Launders, Director of Operations, Device Evaluation, ECRI

Lab tour recording

Current Time 0:00
/
Duration Time 0:00
Progress: NaN%

Presentation slides

N95 Masks—New Guidance

Webcast poll results

ECRI is here to help

Our interdisciplinary staff is here to help you address your most challenging issues in your response to COVID-19. We have compiled free resources in the ECRI COVID-19 Resource Center. Please contact us for assistance and to learn more. 

Summary of recommendations

Additional ECRI Resources

Websites for assessing legitimacy of vendors and imported N95 alternative mask products

Return to the ECRI COVID-19 Resource Center

* All material in this COVID-19 Resource Center, https://www.ecri.org/coronavirus-covid-19-outbreak-preparedness-center/, is protected by copyright, and all rights are reserved under international and Pan-American copyright conventions. However, in light of current circumstances, due to the COVID-19 pandemic, ECRI will permit the ECRI content accessible from this COVID-19 Resource Center to be reproduced and shared, in whole or in part, for non-commercial purposes only. If you desire to reproduce or share content from third-party sources cited within this Center, you must first seek approval from that third-party source.